GlassScriptPhysician profile
Chang Li Lee
NPI 1811197536
$1,198.76
in general payments reported to CMS, 2019-2025
16 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $65.49 · 2021: $180 · 2022: $122 · 2023: $165 · 2024: $189 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $149.41 | 2025 | Myfembree |
| Alexion Pharmaceuticals, INC. | $126.79 | 2023 | |
| Medicem INC. | $121.36 | 2021-2022 | |
| Caldera Medical, INC | $119.55 | 2024 | Desara |
| Aspira Women'S Health INC | $99.04 | 2021-2024 | Ova1 |
| Intuitive Surgical, INC. | $93.00 | 2025 | |
| Merck Sharp & Dohme LLC | $75.63 | 2019-2023 | Gardasil 9 |
| Sage Therapeutics, LLC | $74.26 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $53.45 | 2020-2024 | Aptima |
| Smith+Nephew, INC. | $50.64 | 2022-2025 | Stravix |
| Allergan, INC. | $47.70 | 2019-2020 | |
| Minerva Surgical, INC | $44.59 | 2019-2021 | |
| Abbvie INC. | $40.80 | 2019 | |
| Coopersurgical, INC. | $37.91 | 2022 | |
| Pfizer INC. | $32.39 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $32.24 | 2023-2025 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chang Li Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.